- Research article
- Open Access
- Open Peer Review
Molecular epidemiology of C. diphtheriaestrains during different phases of the diphtheria epidemic in Belarus
BMC Infectious Diseases volume 6, Article number: 129 (2006)
The reemergence of epidemic diphtheria in Belarus in 1990s has provided us with important information on the biology of the disease and the diversity of the causative agent Corynebacterium diphtheriae. Molecular investigations were conducted with the aim to analyze the genetic variability of C diphtheriae during the post-epidemic period.
The biotype and toxigenicity status of 3513 C. diphtheriae strains isolated from all areas in Belarus during a declining period of diphtheria morbidity (1996–2005) was undertaken. Of these, 384 strains were isolated from diphtheria cases, 1968 from tonsillitis patients, 426 from contacts and 735 from healthy carriers. Four hundred and thirty two selected strains were ribotyped.
The C diphtheriae gravis biotype, which was prevalent during 1996–2000, was "replaced" by the mitis biotype during 2001–2005. The distribution of toxigenic C. diphtheriae strains also decreased from 47.1% (1996) to 5.8% (2005). Changes in the distribution of the epidemic ribotypes Sankt-Peterburg and Rossija were also observed. During 2001–2005 the proportion of the Sankt-Peterburg ribotype decreased from 24.3% to 2.3%, in contrast to the Rossija ribotype, that increased from 25.1% to 49.1%. The circulation of other toxigenic ribotypes (Otchakov, Lyon, Bangladesh), which were prevalent during the period of high diphtheria incidence, also decreased. But at the same time, the proportion of non-toxigenic strains with the Cluj and Rossija ribotypes dramatically increased and accounted for 49.3% and 30.1%, respectively.
The decrease in morbidity correlated with the dramatic decrease in the isolation of the gravis biotype and Sankt Peterburg ribotype, and the prevalence of the Rossija ribotype along with other rare ribotypes associated with non-toxigenic strains (Cluj and Rossija, in particular).
The diphtheria epidemic, which emerged in the 1990's in the newly independent states (NIS) of the former Soviet Union, was also reported from Belarus. In Belarus, 794 diphtheria cases were identified during 1990–1995, of which 25 were fatal. As a consequence of mass immunization the morbidity stabilized in 1996. In 2005 the morbidity decreased to 0.11 per 100 000 population with a morbidity index of 0.1/100 000 population in advance of the WHO target for 2010. However, the diphtheria incidence in Belarus remained higher than in previous decades. Prediction of the epidemic process and elimination of diphtheria relies mainly on pathogen circulation analysis. Microbiological monitoring currently includes modern molecular biologic and genetic approaches for the investigatation of C. diphtheriae isolates. A variety of molecular methods including multilocus enzyme electrophoresis, ribotyping, pulsed – field gel electrophoresis, and RAPD have been described. All these showed not only broad circulation of different genotypes but also revealed long-term persistence in regions where manifest severe forms of infections have not been registered [1, 2]. The genetic population of C. diphtheriae was not constant throughout the epidemic process as confirmed by molecular-epidemiologic methods. The prevalence of epidemic strains that belonged to a specific biotype and ribotype was characteristic for each epidemic cycle [3, 4]. Epidemic C. diphtheriae strains, which were prevalent during the diphtheria epidemic in Belarus, belonged to the gravis biotype and were represented by two ribotypes – Sankt-Peterburg and Rossija . The diphtheria epidemics in Russia and the other NIS countries were also associated with these ribotypes [6–11]. Strains of the Rossija ribotype were known to have circulated in some Russian regions five years before the emergence of the epidemic . The data, obtained from molecular-biologic methods, has provided much deeper understanding of the diphtheria epidemic process. However, precise mechanisms of epidemic C. diphtheriae strains' appearance and their elimination remain unclear. The aim of this study was to unveil changes in the C. diphtheriae population during the decrease of diphtheria morbidity in Belarus.
As a result of the implementation of microbiologic screening, a collection of C. diphtheriae strains circulating in Belarus was made at the Institute for Epidemiology and Microbiology in Minsk during 1996–2005. The permission for conducting the study was obtained from the Ethical Committee of the Ministry of Health of Belarus. A total of 3513 C. diphtheriae strains isolated from all areas in Belarus during the period of morbidity decrease were analyzed. Of these, 384 strains were isolated from diphtheria cases, 1968 – from tonsillitis patients, 426 – from contacts, and 735 – from healthy carriers.
Biotyping and toxigenicity testing
Biotyping was performed according to the World Health Organization manual for the laboratory diagnosis of diphtheria . Toxigenicity was determined by the Elek immunoprecipitation method . The strains also were tested for the presence of the diphtheria toxin gene by PCR amplification (with diphtheria toxin gene-specific primers) as described in manual .
Total of 432 C. diphtheriae strains was used for ribotyping. The data for 102 strains was taken from previous study . DNA was extracted by phenol/chloroform method and ribotyping of the strains was performed as previously described [5, 14].
To date, 86 distinct ribotypes with the endonuclease BstEII were chosen for the ribotyping database , and each ribotype pattern is represented by a reference strain possessing a unique geographical name, producing a stable and reproducible ribotype pattern. These reference strains also had common ribotype patterns generated by both endonucleases BstEII and PvuII.
Pheno- and genotyping characteristics of C. diphtheriae strains circulated from 1996 till 2000 correlated well with those from the 2001–2005 period.
C. diphtheriaephenotypic characteristics
Analysis of 2000 C. diphtheriae strains, isolated in 1996–2000, showed that 60.8% belonged to the gravis biotype, 36.7% – to the mitis biotype and 2.5% – to the belfanti biotype (Table 1). Amongst 1513 strains isolated from 2001 to 2005, 54.4%, 39.5% and 6.1% belong to the mitis, gravis and belfanti biotypes respectively. Thus, the diphtheria morbidity decrease was accompanied by changes of the main C. diphtheriae biotypes. During, 1996–2000 the gravis biotype predominated (60.8%) and in 2001–2005 the biotype mitis predominated (54.4%).
Analysis of the toxigenicity of C. diphtheriae by the Elek test showed that during the period of decreased diphtheria morbidity there was a decline in the circulation of toxigenic C. diphtheriae. In 1996, toxigenic strains comprised 47.1% of 486 strains analyzed, in 2005 only 6.8% from 292 examined strains were toxigenic (P < 0.001) (Table 2). A decrease in the proportion of toxigenic strains of the two biotypes was observed: amongst gravis – from 65.8% to 17.5%, amongst mitis – from 12.5% to 0% (Table 2). In 1996–2005, 142 belfanti strains of a total of 3513 were non toxigenic. However, isolates of toxigenic gravis biotype were prevalent among toxigenic strains during the whole period. The proportion ranged from 71.4% – 100.0%.
C. diphtheriaestrains genetic characteristics
Genotypic characteristics of the C. diphtheriae population was based upon ribotype analysis of 432 strains, including 269 toxigenic and 163 non-toxigenic strains. Amongst these, 220 were from diphtheria cases, 116 – from tonsillitis patients, 45 – from contacts, 51 – from healthy carriers. Twenty ribotypes were identified amongst 259 strains, isolated during 1996–2000 (Table 3). Approximately 49.4% were attributed to the two ribotypes: Sankt-Peterburg (24.3%) and Rossija (25.1%). The remainder (50.6%) were represented by 18 ribotypes, which occurred with a frequency range of 0.4 to 16.9. During 2001–2005, the numbers of circulating C. diphtheriae ribotypes decreased to 12, with the Rossija (49.1%) and Cluj ribotypes (20.8%) being prevalent. Ten ribotypes represented the remaining 30.1% strains, which occurred within a frequency range of 0.6 to 11.0%. Evidence from our investigations showed that eight ribotypes, which were prevalent in earlier years, were not identified in the country during 2001–2005. At the same time the circulation level of the Sankt-Peterburg ribotype, which was the predominant epidemic genotype, decreased from 24.3% to 2.3%. This resulted in a comparative increase of the Rossija epidemic ribotype from 25.1% to 49.1%, (P < 0,001) amongst the C. diphtheriae population.
Analysis of the toxigenicity characteristics amongst the various C. diphtheriae ribotypes demonstrated that despite a dramatic decrease in the circulation of toxigenic strains during the period of declining morbidity, the C. diphtheriae ribotypes that predominated were still toxigenic. During 2001–2005, all strains belonging to the Sankt-Peterburg (4 strains), Otchakov (19 strains), Lyon (3 strain), Bangladesh (1 strain) exhibited toxigenic activity (Table 4). A decrease in the proportion of toxigenic strains belonging to the Rossija ribotype (from 93.8% to 74.1%) as well as that of a new ribotype, which was not prevalent in previous years, was reported. We therefore, conclude that in 2001–2005 not only "toxigenic" ribotypes which rarely occurred in the epidemic years were eliminated, but also the proportion of "toxigenic" ribotypes that were prevalent during the high incidence peak decreased from 55.6% to 27.0%. However, the strains of these ribotypes that continued to circulate remained toxigenic.
Distinct features amongst various C. diphtheriae ribotypes were also observed amongst non-toxigenic strains. In 1996–2000 the proportion of non-toxigenic strains from 259 analyzed, accounted for 34.7%, and increased to 42.2% amongst 173 strains examined during 2001–2005. Non-toxigenic C. diphtheriae strains isolated in 1996–2000 were attributed to 11 ribotypes (Table 5). The Moskva (48.9%) and Cluj (36.7%) ribotypes were prevalent within this group. The remainder of non-toxigenic strains (14.4%) was represented by nine ribotypes and occurred at a frequency of 4.5 % – 1.1%. In 2001–2005 the numbers of circulating non-toxigenic C. diphtheriae ribotypes decreased to seven with the Cluj (49.3%) and Rossija (30.1%) ribotypes predominating. Thus, in 2001–2005, the rare ribotypes (Ras-el-Ma, Thailand, Prahova, Dagestan, and Gatchina) were eliminated and other more rarely encountered ribotypes (Close to Pakistan, Neamt) emerged. Strains of the Cluj ribotype continued to prevail within the C. diphtheriae population whilst the proportion of the Moskva ribotype decreased to 11.0%. A relative increase of non-toxigenic strains was observed amongst the Rossija ribotype and as a result were second to the Cluj ribotype.
The morbidity of diphtheria in Belarus decreased as a consequence of mass immunization and was accompanied in 1996 by changes in the circulating population of C. diphtheriae. The gravis biotype which prevailed in 1996–2000 was 'replaced' with the mitis biotype in 2001–2005. This phenomenon of biotype replacement was may be due to colonization resistance by the human population to a single biotype whilst remaining susceptible to the others .
Simultaneously, we observed a decrease in the proportion of toxigenic C. diphtheriae strains from 47.1% (1996) to 6.8% (2005). Toxigenic C. diphtheriae strains offer some selective advantages as compared to non-toxigenic variants in the non-immune human population. The diphtheria toxin induces local tissue changes promoting the colonization and maximum reproduction of bacteria from a clonal group thus contributing to better transmission. These toxigenic strains advantages are not found in immunized individuals . This appears to be a possible explanation for the decrease in the circulation of toxigenic C. diphtheriae strains in a highly immune population.
Ribotyping analysis revealed the elimination of rare ribotypes (toxigenic as well as non-toxigenic) during the period of decreased morbidity. Thus, several ribotypes present 0.8–0.4% during 1996–2000 were completely eliminated. These include Minsk, Gomel, Ras-el-Ma, Thailand, Prahova, Dagestan, Gatchina, Close to Nan, Close to Versailles ribotypes. As regards gravis biotype strains, in 2001–2005 only the Sankt-Peterburg ribotype population dramatically decreased from 24.3% to 2.3%, in contrast, the proportion of the Rossija biotype increased from 25.1% to 49.1%. It is generally believed that surface structures of C. diphtheriae – which are putative colonization factors – display intraspecies differences . Presumably, this could explain the complete disappearance of Sankt-Peterburg ribotype strains whilst preserving another epidemic ribotype – Rossjia. There was a significant increase in the proportion of non-toxigenic strains amongst the total circulating C. diphtheriae with the prevalent ribotypes being Cluj and Rossija (49.1% and 20.8%, respectively) and correlated with the long-term circulation of non-toxigenic strains of the ribotypes Rossija and Cluj. On the other hand, the Rossija ribotype demonstrated a high level of toxigenic strains during 2000–2005 (36.4% of total analysed, 63.0% of total toxigenic strains). Interestingly, a high level of toxigenic strains (100%) was also registered for the Otchakov, Lyon and Bangladesh ribotypes, although their occurrence during 2001–2005 decreased markedly.
In recent years in Belarus, population immunity has increased (92.4% of protected individuals), but the continued circulation of toxigenic C. diphtheriae does not exclude the emergence of sporadic cases of disease, in certain risk groups. A WHO meeting in 1993 concluded that to achieve the elimination of diphtheria, a minimum immunization coverage rate of 90% in children and 75% in adult is required. . From the data available to date it is still unclear whether highly virulent and toxigenic strains will be eliminated from C. diphtheriae population. Rappuoli et al.  suggested that epidemic strains had some selective advantage, such as increased virulence or enhanced ability to colonize and spread. Unfortunately, microbial factors that distinguish epidemic from endemic strains have not been identified [19, 20]. Intense investigation of advantage-giving virulence factors is necessary for epidemic strains – this will allow us to identify conditions necessary for their elimination. Further monitoring of C. diphtheriae circulation in Belarus with molecular-genetic methods as well as determination of molecular-genetic properties in the pathogen population will be the focus of future investigations.
Diphtheria morbidity decreased in Belarus, which was accompanied by significant population changes in the genetic structure of C. diphtheriae. Certain correlations between the genetic evolution of C. diphtheriae and toxin-production have been established.
Eskola J, Lumio J, Vuopio-Varkila J: Resurgent diphtheria – are we safe?. British Medical Bulletin. 1998, 54: 635-645.
Popovic T, Kim C, Reiss J, Reeves M, Nakao H, Golaz A: Use of molecular subtyping to document long-term persistence of Corynebacterium diphtheriae in South Dakota. J Clin Microbiol. 1999, 37: 1092-1099.
Kombarova S, Kim C, Melnikov V, Reeves M, Borisova O, Mazurova I, Popovic T: Rapid identification of Corynebacterium diphtheriae clonal group associated with diphtheria epidemic, Russian Federation. Emerg Infect Dis. 2001, 7: 133-136.
Kombarova S, Mazurova IK, Melnikov VG, Kostyukova NN, Volkovoi KI, Borisova OYu, Platonova TV, Efstratiou A: Genetic structure of Corynebacterium diphtheriae strains isolated in Russia during diphtheria epidemic process of different intensity. Zn Mikrobiol. 2001, 3: 3-8.
Titov L, Kolodkina V, Dronina A, Grimont F, Grimont PA, Lejay-Collin M, De Zoysa A, Andronescu C, Diaconescu A, Marin B, Efstratiou A: Genotypic and phenotypic characteristics of Corynebacterium diphtheriae strains isolated from patients in Belarus during an epidemic period. J Clin Microbiol. 2003, 41: 1285-1288. 10.1128/JCM.41.3.1285-1288.2003.
De Zoysa A, Efstratiou A, George RC, Jahkola M, Vuopio-Varkila J, Deshevoi S, Tseneva G, Rikushin Y: Molecular epidemiology of Corynebacterium diphtheriae from Northwestern Russia and surrounding countries studied by using ribotyping and pulsed-field gel electrophoresis. J Clin Microbiol. 1995, 33: 1080-1083.
Popovic T, Kombarova SY, Reeves MW, Nakao H, Mazurova IK, Wharton M, Wachsmuth IK, Wenger JD: Molecular epidemiology of diphtheria in Russia, 1985–1994. J Infect Dis. 1996, 174: 1064-1072.
Popovic T, Mazurova IK, Efstratiou A, Vuopio-Varkila J, Reeves MW, De Zoysa A, Glushkevich T, Grimont P: Molecular epidemiologyof diphtheria. J Inf Dis. 2000, 168-177. 10.1086/315556. Suppl 1
Sulakvelidze A, Kekelidze M, Gomelauri T, Deng Y, Khetsuriani N, Kobaidze K, De Zoysa A, Efstratiou A, J Morris JG, Imnadze P: Diphtheria in the Republic of Georgia: use of molecular typing techniques for characterization of Corynebacterium diphtheriae strains. J Clin Microbiol. 1999, 37: 3265-3270.
Efstratiou A: Corynebacterium diphtheriae: molecular epidemiology and characterisation studies on epidemic and sporadic isolates. Microbiology and Therapy. 1995, 25: 63-71.
Efstratiou A, George RC: Microbiology and epidemiology of diphtheria. Reviews in Medical Nicrobiology. 1996, 7: 31-42.
Skogen V, Cherkasova VV, Maksimova N, Marston CK, Sjursen H, Reeves MW, Olsvik Ø, Popovic T: Molecular characterization of Corynebacterium diphtheriae isolates, Russia, 1957–1987. Emerg Infect Dis. 2002, 8: 516-518.
Efstratiou A, Maple C: WHO manual for the laboratory diagnosis of diphtheria. Reference no. ICP/EPI 038 (C). Who Regional Office for Europe Copenhagen Denmark. 1994
Regnault B, Grimont F, Grimont PA: Universal ribotyping method using a chemically labelled oligonucleotide probe mixture. Res Microbiol. 1997, 146: 649-659. 10.1016/S0923-2508(99)80064-3.
Grimont PAD, Grimont F, Efstratiou A, De Zoysa A, Mazurova I, Ruckly C, Lejay-Collin M, Martin-Delautre S, Regnault B, European Laboratory Working Group on Diphtheria: International nomenclature for Corynebacterium diphtheriae ribotypes. Res Microbiol. 2004, 155: 162-166. 10.1016/j.resmic.2003.12.005.
Kostyukova NN: Lessons of diphtheria. Zn Mikrobiol. 1999, 2: 92-96.
World Health Organization: Diphtheria epidemic in Europe: emergency and response. Report on a WHO Meeting. St Petersburg, Russia. 5–7 July 1993. 1994, EUR/ICP/EPI 038.
Rappouli R, Perugini M, Falsen E: Molecular epidemiology of the 1984–1986 outbreak of diphtheria in Sweden. N Engl J Med. 1988, 318: 12-4.
Vitek CR, Wharton M: Diphtheria in the former soviet union: reemergence of a pandemic disease. Emerging Infectious Diseases. 1998, 4: 539-550.
Mattos-Guaraldi AL, Moreira LO, Damasco PV, Hirata Júnior R: Diphtheria remains a threat to health in the developing world – an overview. Mem Inst Oswaldo Cruz. 2003, 98: 987-989.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/6/129/prepub
We gratefully acknowledge a grant support of the project "Study of role of non-toxigenic Corynebacterium diphtheriae in the epidemiology of diphtheria" by INTAS (01-2289), 2004.
The authors declare that they have no competing interests.
PADG and FG did the riboryping of C. diphtheriae. AE managed the project. TS collected and provided bacterial isolates. LT wrote the report. VK did the biotyping, toxigenicity of C. diphtheriae, data analysis, wrote the report. All authors read and approved the final manuscript.